ArticleFrontiers in pediatrics2022
Low Prevalence of
Open access · goldAbstract read
In one paragraph
Article in Frontiers in pediatrics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.
0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.4field-weighted citation impact, top 20% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
10 citing papers in PubMed, 8 citations in OpenAlex.
- Genomic profiling of Mexican patients with B-cell precursor acute lymphoblastic leukemia reveals clinically significant somatic and potential germline variants.The journal of pathology. Clinical research · 2026Article
- Article
- [Epidemiology of childhood leukemia in Mexico and Latin America: Effects of vulnerability and social justice].Revista medica del Instituto Mexicano del Seguro Social · 2026Article
- Comprehensive Epigenome-Wide Profiling Reveals Distinctive DNA Methylation Signatures and Potential Prognostic Biomarkers in Mexican Pediatric B-ALL.International journal of molecular sciences · 2025Article
- Somatic Mutations in DNA Mismatch Repair Genes, Mutation Rate and Neoantigen Load in Acute Lymphoblastic Leukemia.Pharmaceuticals (Basel, Switzerland) · 2025Article
- Identification of Molecular Subtypes of B-Cell Acute Lymphoblastic Leukemia in Mexican Children by Whole-Transcriptome Analysis.International journal of molecular sciences · 2025Article
- Editorial: Childhood leukemias in Latin America: epidemiology, causality, novel predictive profiles and therapeutic strategies.Frontiers in oncology · 2024Article
- Review
- Triple-hit explanation for the worse prognosis of pediatric acute lymphoblastic leukemia among Mexican and Hispanic children.Frontiers in oncology · 2022Review
- Persistently high incidence rates of childhood acute leukemias from 2010 to 2017 in Mexico City: A population study from the MIGICCL.Frontiers in public health · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
38 authors at 11 institutions in 1 country.
Minerva Mata-RochaCONACyT-Unidad de Investigacion Medica en Genetica Humana, Hospital de Pediatria, Centro Medico Nacional Siglo XXI, IMSS, Mexico City, Mexico.
Angelica Rangel-LópezCoordinacion de Investigacion en Salud, Unidad Habilitada de Apoyo al Predictamen, Centro Medico Siglo XXI, IMSS, Mexico City, Mexico.
Elva Jimenez-HernandezServicio de Hematologia Pediatrica, Hospital General "Gaudencio González Garza", Centro Medico Nacional (CMN) "La Raza", IMSS, Mexico City, Mexico.
Juan Carlos Nuñez-EnríquezUnidad de Investigacion Medica en Epidemiologia Clinica, Hospital de Pediatria, Centro Medico Nacional Siglo XXI, IMSS, Mexico City, Mexico.
Blanca Angélica Morales-CastilloUnidad de Investigacion Medica en Genética Humana, Hospital de Pediatria, Centro Medico Nacional Siglo XXI, IMSS, Mexico City, Mexico.
Norberto Sánchez-EscobarUnidad de Investigacion Medica en Genética Humana, Hospital de Pediatria, Centro Medico Nacional Siglo XXI, IMSS, Mexico City, Mexico.
Omar Alejandro Sepúlveda-RoblesUnidad de Investigacion Medica en Genética Humana, Hospital de Pediatria, Centro Medico Nacional Siglo XXI, IMSS, Mexico City, Mexico.
Juan Carlos Bravata-AlcántaraLaboratorio de Genética y Diagnóstico Molecular, Hospital Juárez de México, Secretaría de Salud (SSa), Mexico City, Mexico.
Alan Steve Nájera-CortésLaboratorio de Genética y Diagnóstico Molecular, Hospital Juárez de México, Secretaría de Salud (SSa), Mexico City, Mexico.
María Luisa Pérez-SaldivarUnidad de Investigacion Medica en Epidemiologia Clinica, Hospital de Pediatria, Centro Medico Nacional Siglo XXI, IMSS, Mexico City, Mexico.
Janet Flores-LujanoUnidad de Investigacion Medica en Epidemiologia Clinica, Hospital de Pediatria, Centro Medico Nacional Siglo XXI, IMSS, Mexico City, Mexico.
David Aldebarán Duarte-RodríguezUnidad de Investigacion Medica en Epidemiologia Clinica, Hospital de Pediatria, Centro Medico Nacional Siglo XXI, IMSS, Mexico City, Mexico.
Norma Angélica Oviedo de AndaUIM en Inmunología e Infectología, Centro Médico Nacional "La Raza", IMSS, Mexico City, Mexico.
Maria de Los Angeles Romero TlaloliniFacultad de Medicina y Cirugía, UABJO, Oaxaca, Mexico.
Carmen Alaez VersonLaboratorio de Diagnóstico Genómico, Instituto Nacional de Medicina Genómica (INMEGEN), Mexico City, Mexico.
Jorge Alfonso Martín-TrejoServicio de Hematologia, UMAE Hospital de Pediatria, Centro Medico Nacional Siglo XXI, IMSS, Mexico City, Mexico.
Jose Esteban Muñoz MedinaLaboratorio Central de Epidemiología, Centro Médico Nacional "La Raza", Instituto Mexicano del Seguro Social, Mexico City, Mexico.
Cesar Raul Gonzalez-BonillaProfesor de Asignatura de la Facultad de Medicina, UNAM, Mexico City, Mexico.
Maria de Los Angeles Hernandez CuetoCentro Médico Nacional La Raza, División de Laboratorios de Vigilancia e Investigación Epidemiológica, Instituto Mexicano del Seguro Social, Mexico City, Mexico.
V C Bekker-MéndezUIM en Inmunología e Infectología, Centro Médico Nacional "La Raza", IMSS, Mexico City, Mexico.
Silvia Jiménez-MoralesLaboratorio de Genomica del Cancer, Instituto Nacional de Medicina Genómica, Mexico City, Mexico.
Aurora Medina-SansónServicio de Oncología, Hospital Infantil de Mexico Federico Gómez, Secretaria de Salud, Mexico City, Mexico.
Raquel Amador-SánchezServicio de Hematologia Pediatrica, Hospital General Regional "Carlos McGregor Sanchez Navarro", IMSS, Mexico City, Mexico.
José Gabriel Peñaloza-GonzálezServicio de Onco-Pediatria, Hospital Juarez de Mexico, Secretaria de Salud, Mexico City, Mexico.
José Refugio Torres-NavaServicio de Oncología, Hospital Pediatrico de Moctezuma, Secretaria de Salud de la Ciudad de Mexico (SSCDMX), Mexico City, Mexico.
Rosa Martha Espinosa-ElizondoServicio de Hematologia Pediatrica, Hospital General de Mexico, Secretaria de Salud, Mexico City, Mexico.
Beatriz Cortés-HerreraServicio de Hematologia Pediatrica, Hospital General de Mexico, Secretaria de Salud, Mexico City, Mexico.
Luz Victoria Flores-VillegasServicio de Hematologia Pediatrica, Centro Medico Nacional "20 de Noviembre", ISSSTE, Mexico City, Mexico.
Laura Elizabeth Merino-PasayeServicio de Hematologia Pediatrica, Centro Medico Nacional "20 de Noviembre", ISSSTE, Mexico City, Mexico.
Maria de Lourdes Gutierrez-RiveraOncología, UMAE Hospital de Pediatria, Centro Medico Nacional Siglo XXI, IMSS, Mexico City, Mexico.
Martha Margarita Velazquez-AviñaServicio de Onco-Pediatria, Hospital Juarez de Mexico, Secretaria de Salud, Mexico City, Mexico.
Jessica Denisse Santillan-JuarezServicio de Hemato-Oncologia Pediatrica, Hospital Regional 1° de Octubre, ISSSTE, Mexico City, Mexico.
Alma Gurrola-SilvaServicio de Pediatría, Hospital Regional Tipo B de Alta Especialidad Bicentenario de la Independencia, Instituto de Seguridad Social al Servicio de los Trabajadores del Estado, Mexico City, Mexico.
Gabriela Alicia Hernández EcháurreguiServicio de Oncología, Hospital Pediatrico de Moctezuma, Secretaria de Salud de la Ciudad de Mexico (SSCDMX), Mexico City, Mexico.
Alfredo Hidalgo-MirandaLaboratorio de Genomica del Cancer, Instituto Nacional de Medicina Genómica, Mexico City, Mexico.
José Arellano GalindoUnidad de Investigación en Enfermedades Infecciosas, Laboratorio de Virologia Clínica y Experimental, Hospital Infantil de Mexico Federico Gómez, Secretaria de Salud, Mexico City, Mexico.
Haydeé Rosas-VargasUnidad de Investigacion Medica en Genética Humana, Hospital de Pediatria, Centro Medico Nacional Siglo XXI, IMSS, Mexico City, Mexico.
Juan Manuel Mejía-AranguréUnidad de Investigacion Medica en Genética Humana, Hospital de Pediatria, Centro Medico Nacional Siglo XXI, IMSS, Mexico City, Mexico.
Centro Medico Nacional Siglo XXI · MXSecretaria de Salud · MXCentro Médico Nacional La Raza · MXNational Institute of Genomic Medicine · MXInstitute for Social Security and Services for State Workers · MXHospital Juárez de México · MXHospital Pediátrico Moctezuma · MXMexican Social Security Institute · MXBenito Juárez Autonomous University of Oaxaca · MXHospital Regional de Alta Especialidad del Bajío · MXUniversidad Nacional Autónoma de México · MX
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
acute lymphoblastic leukemiafusion genemolecular biomarkersprognosisRT-qPCR
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.